Report copyright - IMMUNOMEDICS, INC.€¦ · Immunomedics’ Next Generation ADC Technology Platform 1. Reduced toxicity 2. Greater dose of drug to tumor 3. Opportunity for long-term, repeated treatments
Please pass captcha verification before submit form